BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25439369)

  • 1. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review.
    Iammatteo M; Blumenthal KG; Saff R; Long AA; Banerji A
    J Allergy Clin Immunol Pract; 2014; 2(6):768-74. PubMed ID: 25439369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of graded challenge in allergic patients.
    Ford MK; Grillo JA; Cohn JR
    J Allergy Clin Immunol Pract; 2015; 3(5):826. PubMed ID: 26122429
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 25439369.
    Iammatteo M; Blumenthal KG; Saff R; Long AA; Banerji A
    J Allergy Clin Immunol Pract; 2015; 3(5):826-7. PubMed ID: 26099817
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges.
    Iammatteo M; Ferastraoaru D; Koransky R; Alvarez-Arango S; Thota N; Akenroye A; Jerschow E
    J Allergy Clin Immunol Pract; 2017; 5(3):711-717.e2. PubMed ID: 27888028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provocation proven drug allergy in Thai children with adverse drug reactions.
    Indradat S; Veskitkul J; Pacharn P; Jirapongsananuruk O; Visitsunthorn N
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):59-64. PubMed ID: 26994627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions during drug challenges: a single US institution's experience.
    Kao L; Rajan J; Roy L; Kavosh E; Khan DA
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):86-91.e1. PubMed ID: 23352526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity.
    Mawhirt SL; Fonacier LS; Calixte R; Davis-Lorton M; Aquino MR
    Ann Allergy Asthma Immunol; 2017 Jan; 118(1):73-79. PubMed ID: 27864093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of antibiotic skin test reactivity in a pediatric population.
    Kamboj S; Yousef E; McGeady S; Hossain J
    Allergy Asthma Proc; 2011; 32(2):99-105. PubMed ID: 21439162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of profitability in the diagnosis of allergy to beta-lactam antibiotics.
    Ferré-Ybarz L; Salinas Argente R; Gómez Galán C; Duocastella Selvas P; Nevot Falcó S
    Allergol Immunopathol (Madr); 2015; 43(4):369-75. PubMed ID: 25087091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of drug provocation tests in Korean children: a single center experience.
    Choi J; Lee JY; Kim KH; Choi J; Ahn K; Kim J
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):130-6. PubMed ID: 27007834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
    Solomon C; Gröner A; Ye J; Pendrak I
    Thromb Haemost; 2015 Apr; 113(4):759-71. PubMed ID: 25502954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and safety of drug provocation tests.
    Aun MV; Bisaccioni C; Garro LS; Rodrigues AT; Tanno LK; Ensina LF; Kalil J; Motta AA; Giavina-Bianchi P
    Allergy Asthma Proc; 2011; 32(4):301-6. PubMed ID: 21781406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams.
    Patriarca G; D'Ambrosio C; Schiavino D; Larocca LM; Nucera E; Milani A
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):257-66. PubMed ID: 10507273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of patients with immediate hypersensitivity to beta-lactams using retest.
    García Núñez I; Barasona Villarejo MJ; Algaba Mármol MA; Moreno Aguilar C; Guerra Pasadas F
    J Investig Allergol Clin Immunol; 2012; 22(1):41-7. PubMed ID: 22448453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study.
    Sikdar KC; Dowden J; Alaghehbandan R; MacDonald D; Peter P; Gadag V
    Ann Pharmacother; 2012; 46(7-8):960-71. PubMed ID: 22739715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge.
    Hjortlund J; Mortz CG; Skov PS; Bindslev-Jensen C
    Allergy; 2013 Aug; 68(8):1057-64. PubMed ID: 23889703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions - allergy? side-effect? intolerance?
    Smith W
    Aust Fam Physician; 2013; 42(1-2):12-6. PubMed ID: 23529453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.